Afsar, C.U.; Karabulut, M.; Karabulut, S.; Tokgoz Ozal, S.; Cikot, M.; Serilmez, M.; Tas, F.
Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer. Biomolecules 2018, 8, 169.
https://doi.org/10.3390/biom8040169
AMA Style
Afsar CU, Karabulut M, Karabulut S, Tokgoz Ozal S, Cikot M, Serilmez M, Tas F.
Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer. Biomolecules. 2018; 8(4):169.
https://doi.org/10.3390/biom8040169
Chicago/Turabian Style
Afsar, Cigdem Usul, Mehmet Karabulut, Senem Karabulut, Safiye Tokgoz Ozal, Murat Cikot, Murat Serilmez, and Faruk Tas.
2018. "Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer" Biomolecules 8, no. 4: 169.
https://doi.org/10.3390/biom8040169
APA Style
Afsar, C. U., Karabulut, M., Karabulut, S., Tokgoz Ozal, S., Cikot, M., Serilmez, M., & Tas, F.
(2018). Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer. Biomolecules, 8(4), 169.
https://doi.org/10.3390/biom8040169